drug

metaxalone

Marketedupdated 2mo ago

by CorePharma LLC

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 32m ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Jul 29, 2039

~13.1 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (2)

Jul 29, 2039formulationUS 11918559
Feb 6, 2026method-of-use (U-915)US 7122566

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying metaxalone

phase4Assess the Effect of Metaxalone 640 mg (M640) Compared to Tizanidine 8 mg on Truck Driving Ability and Cognitioncompletedn=20
phase4Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.active not recruitingn=50
phase4Study to Assess Drowsiness, Cognition, Fall Risk After Metaxalone 640 mg and Metaxalone 800 mgcompletedn=20